{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:20:09Z","timestamp":1767612009700,"version":"3.41.2"},"reference-count":310,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Primary headache disorders, such as migraine, tension-type headache (TTH), and cluster headache, belong to the most common neurological disorders affecting a high percentage of people worldwide. Headache induces a high burden for the affected individuals on the personal level, with a strong impact on life quality, daily life management, and causes immense costs for the healthcare systems. Although a relatively broad spectrum of different pharmacological classes for the treatment of headache disorders are available, treatment effectiveness is often limited by high variances in therapy responses. Genetic variants can influence the individual treatment success by influencing pharmacokinetics or pharmacodynamics of the therapeutic as investigated in the research field of pharmacogenetics. This review summarizes the current knowledge on important primary headache disorders, including migraine, TTH, and cluster headache. We also summarize current acute and preventive treatment options for the three headache disorders based on drug classes and compounds taking important therapy guidelines into consideration. Importantly, the work summarizes and discusses the role of genetic polymorphisms regarding their impact on metabolism safety and the effect of therapeutics that are used to treat migraine, cluster headache, and TTH exploring drug classes such as nonsteroidal anti-inflammatory drugs, triptans, antidepressants, anticonvulsants, calcium channel blockers, drugs with effect on the renin\u2013angiotensin system, and novel headache therapeutics such as ditans, anti-calcitonin-gene-related peptide antibodies, and gepants. Genetic variants in important phase I-, II-, and III-associated genes such as cytochrome P450 genes, UGT genes, and different transporter genes are scrutinized as well as variants in genes important for pharmacodynamics and several functions outside the pharmacokinetic and pharmacodynamic spectrum. Finally, the article evaluates the potential and limitations of pharmacogenetic approaches for individual therapy adjustments in headache disorders.<\/jats:p>","DOI":"10.3389\/fphar.2021.820214","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T16:27:48Z","timestamp":1681403268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacogenetics in Primary Headache Disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"Irina I.","family":"Belyaeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna G.","family":"Subbotina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan I.","family":"Eremenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim V.","family":"Tarasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir N.","family":"Chubarev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helgi B.","family":"Schi\u00f6th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Mwinyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12967-021-02801-w","article-title":"High Efficacy of onabotulinumtoxinA Treatment in Patients with Comorbid Migraine and Depression: a Meta-Analysis","volume":"19","author":"Affatato","year":"2021","journal-title":"J. Transl Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pain.2006.01.016","article-title":"Greater Occipital Nerve Injection in Primary Headache Syndromes-Pprolonged Effects from a Single Injection","volume":"122","author":"Afridi","year":"2006","journal-title":"Pain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5214\/ans.0972.7531.12190210","article-title":"Serotonin and CGRP in Migraine","volume":"19","author":"Aggarwal","year":"2012","journal-title":"Ann. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4193\/rhinol\/19.036","article-title":"Chronic Tension-type Facial Pain-A Pilot Study on HTTLPR Genetic Polymorphisms","volume":"2","author":"Agius","year":"2019","journal-title":"Rhinology Online"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pain.2005.03.008","article-title":"Where Do Triptans Act in the Treatment of Migraine","volume":"115","author":"Ahn","year":"2005","journal-title":"Pain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/PGPM.S273125","article-title":"Genetic Association of Epilepsy and Anti-epileptic Drugs Treatment in Jordanian Patients","volume":"13","author":"Al-Eitan","year":"2020","journal-title":"Pharmgenomics Pers Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"P2","DOI":"10.1186\/1471-2164-15-S2-P2","article-title":"Pharmacogenetics of CYP3A5 on Carbamazepine Pharmacokinetics in Epileptic Patients Developing Toxicity","volume":"15","author":"Al-Gahtany","year":"2014","journal-title":"BMC Genomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.clinthera.2007.07.017","article-title":"Single-dose Intravenous Tramadol for Acute Migraine Pain in Adults: a Single-Blind, Prospective, Randomized, Placebo-Controlled Clinical Trial","volume":"29","author":"Alemdar","year":"2007","journal-title":"Clin. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF00564899","article-title":"Urinary Excretion of Nortriptyline and Five of its Metabolites in Man after Single and Multiple Oral Doses","volume":"5","author":"Alexanderson","year":"1973","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2125.1994.tb04336.x","article-title":"Diazepam Metabolism by Human Liver Microsomes Is Mediated by Both S-Mephenytoin Hydroxylase and CYP3A Isoforms","volume":"38","author":"Andersson","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s40064-016-2211-8","article-title":"Recent Advances in Migraine Therapy","volume":"5","author":"Antonaci","year":"2016","journal-title":"Springerplus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of Aging on Glucuronidation of Valproic Acid in Human Liver Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"B13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-021-00257-2","article-title":"Tension-type Headache","volume":"7","author":"Ashina","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jns.2016.05.019","article-title":"Association of MDR1, CYP2D6, and CYP2C19 Gene Polymorphisms with Prophylactic Migraine Treatment Response","volume":"366","author":"Atasayar","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/j.1526-4610.2011.01990.x","article-title":"OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-week PREEMPT Clinical Program","volume":"51","author":"Aurora","year":"2011","journal-title":"Headache"},{"key":"B16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/cp.1999.v66.100072001","article-title":"Low Frequency of Defective Alleles of Cytochrome P450 Enzymes 2C19 and 2D6 in the Turkish Population","volume":"66","author":"Aynacioglu","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/FPC.0b013e328334b6a3","article-title":"Maternal EPHX1 Polymorphisms and Risk of Phenytoin-Induced Congenital Malformations","volume":"20","author":"Azzato","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/0975-7406.116828","article-title":"Cytochrome P450 2C9 Gene Polymorphism in Phenytoin Induced Gingival Enlargement: A Case Report","volume":"5","author":"Babu","year":"2013","journal-title":"J. Pharm. Bioallied Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.molimm.2007.07.042","article-title":"HLA Class I and Class II Haplotypes in Admixed Families from Several Regions of Mexico","volume":"45","author":"Barquera","year":"2008","journal-title":"Mol. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1468-2982.2000.00070.x","article-title":"Central Sensitization in Tension-type Headache-Ppossible Pathophysiological Mechanisms","volume":"20","author":"Bendtsen","year":"2000","journal-title":"Cephalalgia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1468-1331.2010.03070.x","article-title":"EFNS Guideline on the Treatment of Tension-type Headache - Report of an EFNS Task Force","volume":"17","author":"Bendtsen","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1212\/01.wnl.0000127282.90920.8c","article-title":"Mirtazapine Is Effective in the Prophylactic Treatment of Chronic Tension-type Headache","volume":"62","author":"Bendtsen","year":"2004","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/clpt.1989.40","article-title":"Importance of Genetic Factors in the Regulation of Diazepam Metabolism: Relationship to S-Mephenytoin, but Not Debrisoquin, Hydroxylation Phenotype","volume":"45","author":"Bertilsson","year":"1989","journal-title":"Clin. Pharmacol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum Toxin Type A (BOTOX) for Treatment of Migraine Headaches: an Open-Label Study","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/FPC.0b013e3282f305a9","article-title":"Interaction of CYP2C8 and CYP2C9 Genotypes Modifies the Risk for Nonsteroidal Anti-inflammatory Drugs-Related Acute Gastrointestinal Bleeding","volume":"18","author":"Blanco","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"B26","first-page":"209","article-title":"Cortisone in Allergic Migraine","volume":"35","author":"Blumenthal","year":"1952","journal-title":"Minn. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2217\/pgs-2019-0069","article-title":"The Future of Pharmacogenetics in the Treatment of Migraine","volume":"20","author":"Borro","year":"2019","journal-title":"Pharmacogenomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40263-019-00696-2","article-title":"Pharmacotherapy for Cluster Headache","volume":"34","author":"Brandt","year":"2020","journal-title":"CNS Drugs"},{"key":"B29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2217\/14622416.7.3.271","article-title":"CACNA1C Polymorphisms Are Associated with the Efficacy of Calcium Channel Blockers in the Treatment of Hypertension","volume":"7","author":"Bremer","year":"2006","journal-title":"Pharmacogenomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1055\/s-0037-1607393","article-title":"Migraine in Women","volume":"37","author":"Broner","year":"2017","journal-title":"Semin. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1124\/dmd.105.006866","article-title":"Human In Vitro Glutathionyl and Protein Adducts of Carbamazepine-10,11-Epoxide, a Stable and Pharmacologically Active Metabolite of Carbamazepine","volume":"33","author":"Bu","year":"2005","journal-title":"Drug Metab. Dispos"},{"key":"B32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11940-019-0557-2","article-title":"Antidepressants for Preventive Treatment of Migraine","volume":"21","author":"Burch","year":"2019","journal-title":"Curr. Treat. Options. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mcna.2018.10.003","article-title":"Migraine and Tension-type Headache: Diagnosis and Treatment","volume":"103","author":"Burch","year":"2019","journal-title":"Med. Clin. North. Am."},{"key":"B34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, Burden, and Comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol. Clin."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache"},{"volume-title":"Applied Pharmacokinetics & Pharmacodynamics Principles of Therapeutic Drug Monitoring","year":"2006","author":"Burton","key":"B36"},{"key":"B37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF00168924","article-title":"Cytochromes of the P450 2C Subfamily Are the Major Enzymes Involved in the O-Demethylation of Verapamil in Humans","volume":"353","author":"Busse","year":"1995","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/bs.pbr.2020.06.008","article-title":"The Genetics of Migraine and the Path to Precision Medicine","volume":"255","author":"Cader","year":"2020","journal-title":"Prog. Brain Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/17425255.2018.1541452","article-title":"Pharmacogenetic Considerations for Migraine Therapies","volume":"14","author":"Capi","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/WCO.0000000000000091","article-title":"Migraine and Estrogen","volume":"27","author":"Chai","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(17)30435-0","article-title":"The Pathophysiology of Migraine: Implications for Clinical Management","volume":"17","author":"Charles","year":"2018","journal-title":"Lancet Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12883-018-1013-8","article-title":"Glutathione S-Transferase M1 and T1 Polymorphisms and the Risk of Mild Hepatotoxicity Induced by Carbamazepine in a Tunisian Population Study","volume":"18","author":"Chbili","year":"2018","journal-title":"BMC Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/0333102415610874","article-title":"The Influence of Genetic Constitution on Migraine Drug Responses","volume":"36","author":"Christensen","year":"2016","journal-title":"Cephalalgia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jama.1992.03480090092034","article-title":"The Concepts of Stress and Stress System Disorders. Overview of Physical and Behavioral Homeostasis","volume":"267","author":"Chrousos","year":"1992","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1001\/jama.2009.1855","article-title":"High-flow Oxygen for Treatment of Cluster Headache: a Randomized Trial","volume":"302","author":"Cohen","year":"2009","journal-title":"JAMA"},{"key":"B46","unstructured":"FDA Approves Emgality\u00ae (Galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks2019"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1680","DOI":"10.1002\/mgg3.1680","article-title":"Genetic Variants Related to Successful Migraine Prophylaxis with Verapamil","volume":"9","author":"Cutrer","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00044011-199713010-00005","article-title":"In Vitro and In Vivo Studies on the Disposition of Mirtazapine in Humans","volume":"13","author":"Dahl","year":"1997","journal-title":"Clin. Drug Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1526-4610.2012.02124.x","article-title":"Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment","volume":"52","author":"Dahl\u00f6f","year":"2012","journal-title":"Headache"},{"key":"B50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic Susceptibility to Diclofenac-Induced Hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 Genotypes","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"413PMC6522206","DOI":"10.1097\/WCO.0000000000000687","article-title":"Advance in Genetics of Migraine","volume":"32","author":"de Boer","year":"2019","journal-title":"Curr. Opin. Neurolpmcid"},{"key":"B52","doi-asserted-by":"publisher","first-page":"107528","DOI":"10.1016\/j.pharmthera.2020.107528","article-title":"Pharmacological Treatment of Migraine: CGRP and 5-HT beyond the Triptans","volume":"211","author":"de Vries","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B53","article-title":"Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype","volume-title":"Medical Genetics Summaries [Internet]","author":"Dean","year":""},{"key":"B54","article-title":"Clobazam Therapy and CYP2C19 Genotype","volume-title":"Medical Genetics Summaries [Internet]","author":"Dean","year":""},{"key":"B55","article-title":"Venlafaxine Therapy and CYP2D6 Genotype","volume-title":"Medical Genetics Summaries [Internet]","author":"Dean","year":"2015"},{"key":"B56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","article-title":"Blocking CGRP in Migraine Patients - a Review of Pros and Cons","volume":"18","author":"Deen","year":"2017","journal-title":"J. Headache Pain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/bdrc.20098","article-title":"Effects of Oxidative Stress on Embryonic Development","volume":"81","author":"Dennery","year":"2007","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/j.1468-1331.2011.03361.x","article-title":"A Candidate Gene Study of Antiepileptic Drug Tolerability and Efficacy Identifies an Association of CYP2C9 Variants with Phenytoin Toxicity","volume":"18","author":"Depondt","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"CD011888","DOI":"10.1002\/14651858.CD011888.pub2","article-title":"Aspirin for Acute Treatment of Episodic Tension-type Headache in Adults","volume":"1","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"CD011474","DOI":"10.1002\/14651858.CD011474.pub2","article-title":"Ibuprofen for Acute Treatment of Episodic Tension-type Headache in Adults","volume":"2015","author":"Derry","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/wnl.58.11.1660","article-title":"Efficacy of Oral Ketoprofen in Acute Migraine: a Double-Blind Randomized Clinical Trial","volume":"58","author":"Dib","year":"2002","journal-title":"Neurology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate Reduces Headache Days in Chronic Migraine: a Randomized, Double-Blind, Placebo-Controlled Study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, Prevention, and Treatment of Medication Overuse Headache","volume":"18","author":"Diener","year":"2019","journal-title":"Lancet Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for Treatment of Chronic Migraine: Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT 2 Trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1468-2982.2009.01859.x","article-title":"Utility of Topiramate for the Treatment of Patients with Chronic Migraine in the Presence or Absence of Acute Medication Overuse","volume":"29","author":"Diener","year":"2009","journal-title":"Cephalalgia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1468-2982.1999.019006581.x","article-title":"Efficacy and Safety of Intravenous Acetylsalicylic Acid Lysinate Compared to Subcutaneous Sumatriptan and Parenteral Placebo in the Acute Treatment of Migraine. A Double-Blind, Double-Dummy, Randomized, Multicenter, Parallel Group Study. The ASASUMAMIG Study Group","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1517\/13543784.10.10.1831","article-title":"Advances in Pharmacological Treatment of Migraine","volume":"10","author":"Diener","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B68","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/WNO.0000000000000837","article-title":"What's New in the Treatment of Migraine","volume":"39","author":"Digre","year":"2019","journal-title":"J. Neuroophthalmol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fphar.2014.00210","article-title":"The Effects of Angiotensinogen Gene Polymorphisms on Cardiovascular Disease Outcomes during Antihypertensive Treatment in the GenHAT Study","volume":"5","author":"Do","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A Phase-by-phase Review of Migraine Pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"key":"B71","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/j.1552-4604.1996.tb04754.x","article-title":"Single-dose Pharmacokinetics and Effect of Food on the Bioavailability of Topiramate, a Novel Antiepileptic Drug","volume":"36","author":"Doose","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00228-008-0508-4","article-title":"Relationship between CYP2C8 Genotypes and Diclofenac 5-hydroxylation in Healthy Spanish Volunteers","volume":"64","author":"Dorado","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/tpj.2012.19","article-title":"Neurological Toxicity after Phenytoin Infusion in a Pediatric Patient with Epilepsy: Influence of CYP2C9, CYP2C19 and ABCB1 Genetic Polymorphisms","volume":"13","author":"Dorado","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10194-007-0414-7","article-title":"The Long-Term Efficacy and Safety of Botulinum Toxin in Refractory Chronic Tension-type Headache","volume":"8","author":"Erdemoglu","year":"2007","journal-title":"J. Headache Pain"},{"key":"B75","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s10194-016-0671-4","article-title":"Behavioral Management of Headache in Children and Adolescents","volume":"17","author":"Faedda","year":"2016","journal-title":"J. Headache Pain"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/ijms17081242","article-title":"The Impact of Anti-epileptic Drugs on Growth and Bone Metabolism","volume":"17","author":"Fan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fneur.2018.00714","article-title":"Involvement of the Tetraspanin 2 (TSPAN2) Gene in Migraine: A Case-Control Study in Han Chinese","volume":"9","author":"Fang","year":"2018","journal-title":"Front. Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10194-006-0357-4","article-title":"Aspirin and Tension-type Headache","volume":"8","author":"Farinelli","year":"2007","journal-title":"J. Headache Pain"},{"key":"B79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1474-4422(14)70220-0","article-title":"Migraine Pathophysiology: Lessons from Mouse Models and Human Genetics","volume":"14","author":"Ferrari","year":"2015","journal-title":"Lancet Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/FPC.0000000000000186","article-title":"CYP2C9 Variants as a Risk Modifier of NSAID-Related Gastrointestinal Bleeding: a Case-Control Study","volume":"26","author":"Figueiras","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archneur.1985.04060040072015","article-title":"Treatment of Cluster Headache. A Double-Blind Comparison of Oxygen V Air Inhalation","volume":"42","author":"Fogan","year":"1985","journal-title":"Arch. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40265-018-0894-6","article-title":"OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"key":"B83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1212\/WNL.0b013e3181eb58c8","article-title":"Acute and Preventive Pharmacologic Treatment of Cluster Headache","volume":"75","author":"Francis","year":"2010","journal-title":"Neurology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1055\/s-0039-1700525","article-title":"Migraine Aura: Pathophysiology, Mimics, and Treatment Options","volume":"39","author":"Fraser","year":"2019","journal-title":"Semin. Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nrl.2015.03.005","article-title":"Pharmacogenetics of Adverse Reactions to Antiepileptic Drugs","volume":"33","author":"Fricke-Galindo","year":"","journal-title":"Neurologia"},{"key":"B86","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/17512433.2018.1486707","article-title":"Carbamazepine Adverse Drug Reactions","volume":"11","author":"Fricke-Galindo","year":"","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B87","first-page":"882","article-title":"Cortisone in Migraine and Histamine Headaches","volume":"50","author":"Frohner","year":"1953","journal-title":"Rocky Mt Med. J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cca.2007.11.035","article-title":"Glutathione-S-transferase (GST) M1 Null Genotype and Combined GSTM1 and GSTT1 Null Genotypes Are Risk Factors for Increased Serum Gamma-Glutamyltransferase in Valproic Acid-Treated Patients","volume":"389","author":"Fukushima","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"B89","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","article-title":"\u03b2-Blockers: Their New Life from Hypertension to Cancer and Migraine","volume":"151","author":"Fumagalli","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B90","first-page":"92","article-title":"Divalproex Sodium in the Treatment of Migraine and Cluster Headaches","volume":"102","author":"Gallagher","year":"2002","journal-title":"J. Am. Osteopath Assoc."},{"key":"B91","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/0333102412443335","article-title":"Efficacy and Safety of 121 Injections of the Greater Occipital Nerve in Episodic and Chronic Cluster Headache","volume":"32","author":"Gantenbein","year":"2012","journal-title":"Cephalalgia"},{"key":"B92","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/15622975.2013.832380","article-title":"Genetic Variation in the Serotonin Transporter and HTR1B Receptor Predicts Reduced Bone Formation during Serotonin Reuptake Inhibitor Treatment in Older Adults","volume":"15","author":"Garfield","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"B93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1528-1157.2000.tb02174.x","article-title":"Clinical Pharmacology of Topiramate: a Review","volume":"41","author":"Garnett","year":"2000","journal-title":"Epilepsia"},{"key":"B94","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0333102416654886","article-title":"Efficacy and Safety of a Single Occipital Nerve Blockade in Episodic and Chronic Cluster Headache: a Prospective Observational Study","volume":"37","author":"Gaul","year":"2017","journal-title":"Cephalalgia"},{"key":"B95","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10194-010-0241-0","article-title":"Genetic Polymorphisms Related to Efficacy and Overuse of Triptans in Chronic Migraine","volume":"11","author":"Gentile","year":"2010","journal-title":"J. Headache Pain"},{"key":"B96","first-page":"1205","article-title":"Headache (Chronic Tension-type)","volume":"2016","author":"Ghadiri-Sani","year":"2016","journal-title":"BMJ Clin. Evid."},{"key":"B97","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic Acid Pathway: Pharmacokinetics and Pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e14520","DOI":"10.1097\/MD.0000000000014520","article-title":"A Randomized Trial of Trigger point Dry Needling versus Sham Needling for Chronic Tension-type Headache","volume":"98","author":"Gildir","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B99","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3810\/pgm.2012.05.2554","article-title":"Role of Dexamethasone in the Prevention of Migraine Recurrence in the Acute Care Setting: A Review","volume":"124","author":"Giuliano","year":"2012","journal-title":"Postgrad. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, Regional, and National burden of Migraine and Tension-type Headache, 1990-2016: a Systematic Analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of Migraine: A Disorder of Sensory Processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol. Rev."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2217\/pgs-2016-0113","article-title":"Pharmacogenomics and Histone Deacetylase Inhibitors","volume":"17","author":"Goey","year":"2016","journal-title":"Pharmacogenomics"},{"key":"B103","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00008571-199702000-00008","article-title":"Frequencies of the Defective CYP2C19 Alleles Responsible for the Mephenytoin Poor Metabolizer Phenotype in Various Oriental, Caucasian, Saudi Arabian and American Black Populations","volume":"7","author":"Goldstein","year":"1997","journal-title":"Pharmacogenetics"},{"key":"B104","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jocn.2019.07.009","article-title":"Suboccipital Steroid Injection Alone as a Preventive Treatment for Cluster Headache","volume":"68","author":"G\u00f6nen","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/FPC.0000000000000057","article-title":"PharmGKB Summary: Tramadol Pathway","volume":"24","author":"Gong","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"B106","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3598","article-title":"Meta-analysis of 375,000 Individuals Identifies 38 Susceptibility Loci for Migraine","volume":"48","author":"Gormley","year":"2016","journal-title":"Nat. Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","article-title":"Mechanism of Action of Paracetamol","volume":"12","author":"Graham","year":"2005","journal-title":"Am. J. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1523\/jneurosci.23-18-07069.2003","article-title":"Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons","volume":"23","author":"Gryder","year":"2003","journal-title":"J. Neurosci."},{"key":"B109","first-page":"17","article-title":"Migraine Headache Prophylaxis","volume":"99","author":"Ha","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"B110","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40263-019-00630-6","article-title":"Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets","volume":"33","author":"Haanes","year":"2019","journal-title":"CNS Drugs"},{"key":"B111","first-page":"682","article-title":"Approach to Acute Headache in Adults","volume":"87","author":"Hainer","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"B112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11940-016-0397-2","article-title":"ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They","volume":"18","author":"Halker","year":"2016","journal-title":"Curr. Treat. Options. Neurol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jamda.2016.09.02110.1016\/j.jamda.2016.09.021","article-title":"CYP2C9 Genotypes Modify Benzodiazepine-Related Fall Risk: Original Results from Three Studies with Meta-Analysis","volume":"18","author":"Ham","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/epi.12655","article-title":"Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 Polymorphisms with the Risk of Carbamazepine-Induced Stevens-Johnson Syndrome\/toxic Epidermal Necrolysis in Chinese Han Patients with Epilepsy","volume":"55","author":"He","year":"2014","journal-title":"Epilepsia"},{"key":"B115","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.arcmed.2017.03.003","article-title":"RAS Genetic Variants in Interaction with ACE Inhibitors Drugs Influences Essential Hypertension Control","volume":"48","author":"Heidari","year":"2017","journal-title":"Arch. Med. Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"CD011616","DOI":"10.1002\/14651858.CD011616.pub2","article-title":"Botulinum Toxins for the Prevention of Migraine in Adults","volume":"6","author":"Herd","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1468-2982.1989.0903195.x","article-title":"Sodium Valproate in the Treatment of Cluster Headache: an Open Clinical Trial","volume":"9","author":"Hering","year":"1989","journal-title":"Cephalalgia"},{"key":"B118","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/clpt.2013.2","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants","volume":"93","author":"Hicks","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"B119","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of Acetaminophen-Induced Liver Necrosis","volume":"196","author":"Hinson","year":"2010","journal-title":"Handb Exp. Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2169\/internalmedicine.46.6226","article-title":"Multi-center Randomized Control Trial of Etizolam Plus NSAID Combination for Tension-type Headache","volume":"46","author":"Hirata","year":"2007","journal-title":"Intern. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41397-019-0131-z","article-title":"OPRM1, OPRK1, and COMT Genetic Polymorphisms Associated with Opioid Effects on Experimental Pain: a Randomized, Double-Blind, Placebo-Controlled Study","volume":"20","author":"Ho","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","article-title":"Efficacy and Tolerability of MK-0974 (Telcagepant), a New Oral Antagonist of Calcitonin Gene-Related Peptide Receptor, Compared with Zolmitriptan for Acute Migraine: a Randomised, Placebo-Controlled, Parallel-Treatment Trial","volume":"372","author":"Ho","year":"2008","journal-title":"Lancet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1526-4610.1995.hed3502065.x","article-title":"Transnasal Butorphanol in the Treatment of Acute Migraine","volume":"35","author":"Hoffert","year":"1995","journal-title":"Headache"},{"key":"B124","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","article-title":"Diagnosis, Pathophysiology, and Management of Cluster Headache","volume":"17","author":"Hoffmann","year":"2018","journal-title":"Lancet Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic Susceptibility to Carbamazepine-Induced Cutaneous Adverse Drug Reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"B126","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/ph14030204","article-title":"Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters","volume":"14","author":"Iannaccone","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","article-title":"HLA Class I Markers in Japanese Patients with Carbamazepine-Induced Cutaneous Adverse Reactions","volume":"51","author":"Ikeda","year":"2010","journal-title":"Epilepsia"},{"key":"B128","first-page":"605","article-title":"Metabolism of Diazepam In Vitro by Human Liver. Independent Variability of N-Demethylation and C3-Hydroxylation","volume":"16","author":"Inaba","year":"1988","journal-title":"Drug Metab. Dispos"},{"key":"B129","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10072-011-0716-z","article-title":"Negative Predictors of Clinical Response to Triptans in Patients with Migraine","volume":"33","author":"Ishii","year":"2012","journal-title":"Neurol. Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-4165(90)90079-c","article-title":"The Enzymatic Basis for the Metabolism and Inhibitory Effects of Valproic Acid: Dehydrogenation of Valproyl-CoA by 2-Methyl-Branched-Chain Acyl-CoA Dehydrogenase","volume":"1034","author":"Ito","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"B131","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","article-title":"CGRP and the Trigeminal System in Migraine","volume":"59","author":"Iyengar","year":"2019","journal-title":"Headache"},{"key":"B132","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: Past, Present, and Future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1111\/j.1528-1157.1997.tb04512.x","article-title":"Pharmacokinetics and Interaction Profile of Topiramate: Review and Comparison with Other Newer Antiepileptic Drugs","volume":"38","author":"Johannessen","year":"1997","journal-title":"Epilepsia"},{"key":"B134","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/01.JGP.0000204328.50105.b3","article-title":"Cardiovascular Changes Associated with Venlafaxine in the Treatment of Late-Life Depression","volume":"14","author":"Johnson","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B135","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1756285616684494","article-title":"Diclofenac Potassium for Oral Solution (CAMBIA\u00ae) in the Acute Management of a Migraine Attack: Clinical Evidence and Practical Experience","volume":"10","author":"Joshi","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00228-010-0850-1","article-title":"The Role of CYP2D6 and ABCB1 Pharmacogenetics in Drug-Na\u00efve Patients with First-Episode Schizophrenia Treated with Risperidone","volume":"66","author":"Jovanovi\u0107","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1253\/circj.cj-08-0761","article-title":"Genetic Polymorphisms of L-type Calcium Channel alpha1C and alpha1D Subunit Genes Are Associated with Sensitivity to the Antihypertensive Effects of L-type Dihydropyridine Calcium-Channel Blockers","volume":"73","author":"Kamide","year":"2009","journal-title":"Circ. J."},{"key":"B138","article-title":"Cluster Headache","volume-title":"StatPearls [Internet]","author":"Kandel","year":"2021"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"HLA-B*1511 Is a Risk Factor for Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japanese Patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.clinbiochem.2014.05.065","article-title":"Pharmacogenetics of Chronic Pain Management","volume":"47","author":"Kapur","year":"2014","journal-title":"Clin. Biochem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1248\/bpb.19.1511","article-title":"Oxidative Metabolism of Flunarizine and Cinnarizine by Microsomes from B-Lymphoblastoid Cell Lines Expressing Human Cytochrome P450 Enzymes","volume":"19","author":"Kariya","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"B142","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cpt.2008","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update","volume":"109","author":"Karnes","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00008571-199412000-00010","article-title":"The Importance of Substrate Concentration in Determining Cytochromes P450 Therapeutically Relevant In Vivo","volume":"4","author":"Kato","year":"1994","journal-title":"Pharmacogenetics"},{"key":"B144","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/00008571-200112000-00008","article-title":"Identification of a Null Allele of CYP2C9 in an African-American Exhibiting Toxicity to Phenytoin","volume":"11","author":"Kidd","year":"2001","journal-title":"Pharmacogenetics"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e13818","DOI":"10.1371\/journal.pone.0013818","article-title":"Genome-wide and Follow-Up Studies Identify CEP68 Gene Variants Associated with Risk of Aspirin-Intolerant Asthma","volume":"5","author":"Kim","year":"2010","journal-title":"PLoS One"},{"key":"B146","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/FPC.0b013e328338073a","article-title":"A Nonsynonymous Variation in MRP2\/ABCC2 Is Associated with Neurological Adverse Drug Reactions of Carbamazepine in Patients with Epilepsy","volume":"20","author":"Kim","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"B147","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/JCP.0b013e318160f827","article-title":"Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol","volume":"28","author":"Kirchheiner","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3390\/ijms19061707","article-title":"The Role of Genetic Polymorphisms in Chronic Pain Patients","volume":"19","author":"Knezevic","year":"2018","journal-title":"Ijms"},{"key":"B149","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2298\/mpns1302053k","article-title":"Pathophysiology of Migraine-Ffrom Molecular to Personalized Medicine","volume":"66","author":"Koji\u0107","year":"2013","journal-title":"Med. Pregl"},{"key":"B150","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1055\/s-2008-1073024","article-title":"The Metabolization of Carbamazepine to CBZ-10,11-Epoxide in Children from the Newborn Age to Adolescence","volume":"25","author":"Korinthenberg","year":"1994","journal-title":"Neuropediatrics"},{"key":"B151","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/BF00169164","article-title":"Identification of P450 Enzymes Involved in Metabolism of Verapamil in Humans","volume":"348","author":"Kroemer","year":"1993","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1526-4610.1981.hed2101001.x","article-title":"Response of Cluster Headache Attacks to Oxygen Inhalation","volume":"21","author":"Kudrow","year":"1981","journal-title":"Headache"},{"key":"B153","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/dmd.105.005652","article-title":"Glucuronidation of the Aspirin Metabolite Salicylic Acid by Expressed UDP-Glucuronosyltransferases and Human Liver Microsomes","volume":"34","author":"Kuehl","year":"2006","journal-title":"Drug Metab. Dispos"},{"key":"B154","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence Diversity in CYP3A Promoters and Characterization of the Genetic Basis of Polymorphic CYP3A5 Expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat. Genet."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/jnnp.2008.157743","article-title":"Cranial Autonomic Symptoms in Migraine: Characteristics and Comparison with Cluster Headache","volume":"80","author":"Lai","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B156","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1468-2982.2000.00101.x","article-title":"Acetylsalicylic Acid Effervescent 1000 Mg (Aspirin) in Acute Migraine Attacks; a Multicentre, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Parallel Group Study","volume":"20","author":"Lange","year":"2000","journal-title":"Cephalalgia"},{"key":"B157","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/PGPM.S129908","article-title":"CYP2C19*2 Status in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis","volume":"10","author":"Laska","year":"2017","journal-title":"Pharmgenomics Pers Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/nedt.1.1.59.52296","article-title":"Onset of Improvement and Response to Mirtazapine in Depression: a Multicenter Naturalistic Study of 4771 Patients","volume":"1","author":"Lavergne","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B159","doi-asserted-by":"publisher","first-page":"CD008042PMC6494511","DOI":"10.1002\/14651858.CD008042.pub3","article-title":"Triptans for Acute Cluster Headache","volume":"2013","author":"Law","year":"2013","journal-title":"Cochrane Database Syst. Revpmcid"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1517\/14656560902942046","article-title":"Pharmacotherapy of Tension-type Headache (TTH)","volume":"10","author":"Lenaerts","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1212\/wnl.54.6.1382","article-title":"Verapamil in the Prophylaxis of Episodic Cluster Headache: a Double-Blind Study versus Placebo","volume":"54","author":"Leone","year":"2000","journal-title":"Neurology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"e2311","DOI":"10.1002\/brb3.2311","article-title":"Drug Use Evaluation: A Two-Year Retrospective Review of the Effectiveness and Tolerability of Agomelatine versus Mirtazapine in Patients with Depressive Disorder","volume":"11","author":"Leung","year":"2021","journal-title":"Brain Behav."},{"key":"B163","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The Cost of Headache Disorders in Europe: the Eurolight Project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1001\/archinte.160.22.3486","article-title":"Efficacy and Safety of Acetaminophen in the Treatment of Migraine: Results of a Randomized, Double-Blind, Placebo-Controlled, Population-Based Study","volume":"160","author":"Lipton","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"e1365","DOI":"10.1212\/WNL.0000000000009169","article-title":"Efficacy and Safety of Eptinezumab in Patients with Chronic Migraine: PROMISE-2","volume":"94","author":"Lipton","year":"2020","journal-title":"Neurology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00415-018-9007-4","article-title":"Cluster Headache: Pathophysiology, Diagnosis and Treatment","volume":"266","author":"Ljubisavljevic","year":"2019","journal-title":"J. Neurol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN Guidelines for Prevention of Episodic Migraine: a Summary and Comparison with Other Recent Clinical Practice Guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1074\/jbc.M008119200","article-title":"A Novel Bifunctional Phospholipase C that Is Regulated by Galpha 12 and Stimulates the Ras\/mitogen-Activated Protein Kinase Pathway","volume":"276","author":"Lopez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B169","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/17425251003693547","article-title":"Valproate Semisodium ER for Migraine and Cluster Headache Prophylaxis","volume":"6","author":"Lovell","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1526-4610.2004.04055.x","article-title":"Outpatient Intravenous Dihydroergotamine for Refractory Cluster Headache","volume":"44","author":"Magnoux","year":"2004","journal-title":"Headache"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s10552-013-0282-1","article-title":"COX-1 (PTGS1) and COX-2 (PTGS2) Polymorphisms, NSAID Interactions, and Risk of colon and Rectal Cancers in Two Independent Populations","volume":"24","author":"Makar","year":"2013","journal-title":"Cancer Causes Control"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1528-1157.1998.tb01330.x","article-title":"The Effects of Genetic Polymorphisms of CYP2C9 and CYP2C19 on Phenytoin Metabolism in Japanese Adult Patients with Epilepsy: Studies in Stereoselective Hydroxylation and Population Pharmacokinetics","volume":"39","author":"Mamiya","year":"1998","journal-title":"Epilepsia"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1015941","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 Allele and Antiepileptic Drug-Induced Cutaneous Reactions in Han ChineseErratum in","volume":"4849","author":"Man","year":"2007","journal-title":"EpilepsiaEpilepsia"},{"key":"B174","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.compbiolchem.2014.05.002","article-title":"A Computational prospect to Aspirin Side Effects: Aspirin and COX-1 Interaction Analysis Based on Non-synonymous SNPs","volume":"51","author":"Marjan","year":"2014","journal-title":"Comput. Biol. Chem."},{"key":"B175","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s40263-018-0555-z","article-title":"Refining the Benefit\/Risk Profile of Anti-epileptic Drugs in Headache Disorders","volume":"32","author":"Marmura","year":"2018","journal-title":"CNS Drugs"},{"key":"B176","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The Acute Treatment of Migraine in Adults: the American Headache Society Evidence Assessment of Migraine Pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"key":"B177","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11916-018-0734-0","article-title":"Triggers, Protectors, and Predictors in Episodic Migraine","volume":"22","author":"Marmura","year":"2018","journal-title":"Curr. Pain Headache Rep."},{"key":"B178","doi-asserted-by":"publisher","first-page":"18006","DOI":"10.1038\/nrdp.2018.6","article-title":"Cluster Headache","volume":"4","author":"May","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B179","first-page":"243","article-title":"Acute Migraine Headache: Treatment Strategies","volume":"97","author":"Mayans","year":"2018","journal-title":"Am. Fam. Physician"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"684162","DOI":"10.3389\/fphar.2021.684162","article-title":"Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity","volume":"12","author":"McEvoy","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B182","article-title":"Calcium Channel Blockers","volume-title":"StatPearls [Internet]","author":"McKeever","year":"2021"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/head.13922","article-title":"An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of MWA or MWoA in Pediatric Participants","volume":"60","author":"McVige","year":"2020","journal-title":"Headache"},{"key":"B184","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/clpt.1981.147","article-title":"E- and Z-10-Hydroxylation of Nortriptyline: Relationship to Polymorphic Debrisoquine Hydroxylation","volume":"30","author":"Mellstr\u00f6m","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"B185","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/j.psyneuen.2009.06.004","article-title":"Evidence for a Key Role of Steroids in the Modulation of Pain","volume":"34","author":"Mensah-Nyagan","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"B186","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A New Benzodiazepine Pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B187","first-page":"154","article-title":"Effect of NOS3 Gene Polymorphism on Response to Tricyclic Antidepressants in Migraine Attacks","volume":"13","author":"Molana","year":"2014","journal-title":"Iranian J. Neurol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11916-009-0075-0","article-title":"Tension-type Headache with Medication Overuse: Pathophysiology and Clinical Implications","volume":"13","author":"Monteith","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"B189","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/WCO.0000000000000806","article-title":"Gepants, Calcitonin-Gene-Related Peptide Receptor Antagonists: what Could Be Their Role in Migraine Treatment","volume":"33","author":"Moreno-Ajona","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s10194-019-0989-9","article-title":"CALCA and TRPV1 Genes Polymorphisms Are Related to a Good Outcome in Female Chronic Migraine Patients Treated with OnabotulinumtoxinA","volume":"20","author":"Moreno-Mayordomo","year":"2019","journal-title":"J. Headache Pain"},{"key":"B191","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.me.44.020193.001045","article-title":"SUMATRIPTAN: a Receptor-Targeted Treatment for Migraine","volume":"44","author":"Moskowitz","year":"1993","journal-title":"Annu. Rev. Med."},{"key":"B192","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1006\/bbrc.2000.3210","article-title":"Hepatic Metabolism of Ergot Alkaloids in Beef Cattle by Cytochrome P450","volume":"274","author":"Moubarak","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B193","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/JPR.S42040","article-title":"Consequences of the 118A>G Polymorphism in the OPRM1 Gene: Translation from Bench to Bedside","volume":"6","author":"Mura","year":"2013","journal-title":"J. Pain Res."},{"volume-title":"Headaches: Diagnosis and Management of Headaches in Young People and Adults","year":"2012","key":"B194"},{"key":"B195","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/13543784.2019.1618830","article-title":"Gepants for the Treatment of Migraine","volume":"28","author":"Negro","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B196","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11916-020-00892-6","article-title":"Epidemiology of Headache in Children and Adolescents-Another Type of Pandemia","volume":"24","author":"Nieswand","year":"2020","journal-title":"Curr. Pain Headache Rep."},{"key":"B197","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007691-200004000-00016","article-title":"Genetic Polymorphism of the CYP2C Subfamily and Excessive Serum Phenytoin Concentration with central Nervous System Intoxication","volume":"22","author":"Ninomiya","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"B198","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1161\/CIRCGENETICS.110.957654","article-title":"Genetic Variation in the Beta2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association with Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)","volume":"3","author":"Niu","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders, 3rd Edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"B200","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/ane.12473","article-title":"Cytochrome P450 2C19 Polymorphisms and Valproic Acid-Induced Weight Gain","volume":"133","author":"Noai","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"B201","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1474-4422(20)30363-X","article-title":"Safety and Efficacy of Prednisone versus Placebo in Short-Term Prevention of Episodic Cluster Headache: a Multicentre, Double-Blind, Randomised Controlled Trial","volume":"20","author":"Obermann","year":"2021","journal-title":"Lancet Neurol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","article-title":"Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action","volume":"15","author":"Ong","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B203","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0333102414535997","article-title":"Canadian Headache Society Systematic Review and Recommendations on the Treatment of Migraine Pain in Emergency Settings","volume":"35","author":"Orr","year":"2015","journal-title":"Cephalalgia"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of Opioid Pharmacogenetics and Considerations for Pain Management","volume":"37","author":"Owusu Obeng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B205","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0895-4356(96)00056-x","article-title":"Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA)","volume":"49","author":"Pahor","year":"1996","journal-title":"J. Clin. Epidemiol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/AJP.0000000000000685","article-title":"Variables Associated with the Use of Prophylactic Amitriptyline Treatment in Patients with Tension-type Headache","volume":"35","author":"Palacios-Ce\u00f1a","year":"2019","journal-title":"Clin. J. Pain"},{"key":"B207","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3390\/ph3061966","article-title":"NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data","volume":"3","author":"Pardutz","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"B208","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.clpt.2006.02.008","article-title":"Effect of CYP3A5*3 Genotype on the Pharmacokinetics and Pharmacodynamics of Alprazolam in Healthy Subjects","volume":"79","author":"Park","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"B209","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s12098-020-03315-x","article-title":"Paracetamol versus Ibuprofen for the Acute Treatment of Migraine Headache in Children: A Blinded Randomized Controlled Trial","volume":"87","author":"Pavithra","year":"2020","journal-title":"Indian J. Pediatr."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1124\/dmd.30.11.1170","article-title":"Pathways of Carbamazepine Bioactivation In Vitro I. Characterization of Human Cytochromes P450 Responsible for the Formation of 2- and 3-hydroxylated Metabolites","volume":"30","author":"Pearce","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"B211","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"B212","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/0333102419884935","article-title":"Major Depression Subtypes Are Differentially Associated with Migraine Subtype, Prevalence and Severity","volume":"40","author":"Pisanu","year":"2020","journal-title":"Cephalalgia"},{"key":"B213","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00439-017-1816-5","article-title":"A Genetic Risk Score Is Differentially Associated with Migraine with and without Aura","volume":"136","author":"Pisanu","year":"","journal-title":"Hum. Genet."},{"key":"B214","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102416648650","article-title":"High Leptin Levels Are Associated with Migraine with Aura","volume":"37","author":"Pisanu","year":"","journal-title":"Cephalalgia"},{"key":"B215","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40263-018-0532-6","article-title":"Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine","volume":"32","author":"Pomes","year":"2018","journal-title":"CNS Drugs"},{"key":"B216","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-019-1010-3","article-title":"Optimising Migraine Treatment: from Drug-Drug Interactions to Personalized Medicine","volume":"20","author":"Pomes","year":"2019","journal-title":"J. Headache Pain"},{"key":"B217","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/b:nere.0000010456.92887.3b","article-title":"Modulation by Topiramate of AMPA and Kainate Mediated Calcium Influx in Cultured Cerebral Cortical, Hippocampal and Cerebellar Neurons","volume":"29","author":"Poulsen","year":"2004","journal-title":"Neurochem. Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00415-017-8434-y","article-title":"An Update on Migraine: Current Understanding and Future Directions","volume":"264","author":"Puledda","year":"2017","journal-title":"J. Neurol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0009-9236(99)90075-9","article-title":"Effect of the Gene Dosage of CgammaP2C19 on Diazepam Metabolism in Chinese Subjects","volume":"66","author":"Qin","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"B220","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11910-014-0520-2","article-title":"Tension-type Headache and Sleep","volume":"15","author":"Rains","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B221","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4103\/0028-3886.33300","article-title":"Severe Phenytoin Toxicity in a CYP2C9*3*3 Homozygous Mutant from India","volume":"55","author":"Ramasamy","year":"2007","journal-title":"Neurol. India"},{"key":"B222","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1517\/14656566.2013.806487","article-title":"Activation of 5-hydroxytryptamine1B\/1D\/1F Receptors as a Mechanism of Action of Antimigraine Drugs","volume":"14","author":"Ram\u00edrez Rosas","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"B223","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2165\/00023210-200418100-00004","article-title":"Intranasal Medications for the Treatment of Migraine and Cluster Headache","volume":"18","author":"Rapoport","year":"2004","journal-title":"CNS Drugs"},{"key":"B224","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/jgs.14936","article-title":"Bone Turnover with Venlafaxine Treatment in Older Adults with Depression","volume":"65","author":"Rawson","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"B225","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10072-018-3338-x","article-title":"What the Pharmacological Management of Migraine Can Tell Us about the Future of Migraine Patient Care","volume":"39","author":"Rizzoli","year":"2018","journal-title":"Neurol. Sci."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/head.12866","article-title":"Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines","volume":"56","author":"Robbins","year":"2016","journal-title":"Headache"},{"key":"B227","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0333102414550416","article-title":"Adverse Cardiovascular Events Associated with Triptans and Ergotamines for Treatment of Migraine: Systematic Review of Observational Studies","volume":"35","author":"Roberto","year":"2015","journal-title":"Cephalalgia"},{"key":"B228","doi-asserted-by":"publisher","first-page":"613PMC1737364","DOI":"10.1136\/jnnp.70.5.613","article-title":"Cluster Headache in Women: Clinical Characteristics and Comparison with Cluster Headache in Men","volume":"70","author":"Rozen","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatrypmcid"},{"key":"B229","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10194-007-0366-y","article-title":"Genetics of Tension-type Headache","volume":"8","author":"Russell","year":"2007","journal-title":"J. Headache Pain"},{"key":"B230","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10194-005-0253-3","article-title":"Tension-type Headache in 40-Year-Olds: a Danish Population-Based Sample of 4000","volume":"6","author":"Russell","year":"2005","journal-title":"J. Headache Pain"},{"key":"B231","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10194-018-0955-y","article-title":"European Headache Federation Guideline on the Use of Monoclonal Antibodies Acting on the Calcitonin Gene Related Peptide or its Receptor for Migraine Prevention","volume":"20","author":"Sacco","year":"2019","journal-title":"J. Headache Pain"},{"key":"B232","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1038\/s41598-021-83508-2","article-title":"Real World Effectiveness and Tolerability of Candesartan in the Treatment of Migraine: a Retrospective Cohort Study","volume":"11","author":"S\u00e1nchez-Rodr\u00edguez","year":"2021","journal-title":"Sci. Rep."},{"key":"B233","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1007\/s10194-012-0437-6","article-title":"Italian Guidelines for Primary Headaches: 2012 Revised Version","volume":"13","author":"Sarchielli","year":"2012","journal-title":"J. Headache Pain"},{"key":"B234","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0038-1646946","article-title":"The Global Burden of Headache","volume":"38","author":"Saylor","year":"2018","journal-title":"Semin. Neurol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5688\/aj700598","article-title":"Ergot and its Alkaloids","volume":"70","author":"Schiff","year":"2006","journal-title":"Am. J. Pharm. Educ."},{"key":"B236","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-017-0741-2","article-title":"Calcitonin Gene-Related Peptide and Pain: a Systematic Review","volume":"18","author":"Schou","year":"2017","journal-title":"J. Headache Pain"},{"key":"B237","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","article-title":"Prophylactic Treatment of Migraine with Angiotensin Converting Enzyme Inhibitor (Lisinopril): Randomised, Placebo Controlled, Crossover Study","volume":"322","author":"Schrader","year":"2001","journal-title":"BMJ"},{"key":"B238","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/sj.clpt.6100159","article-title":"G Protein Beta3 Polymorphism and Triptan Response in Cluster Headache","volume":"82","author":"Sch\u00fcrks","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"B239","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1468-2982.2008.01705.x","article-title":"Prevalence of Primary Headaches and Cranial Neuralgias in Men and Women Aged 55-94 Years (Bruneck Study)","volume":"29","author":"Schwaiger","year":"2009","journal-title":"Cephalalgia"},{"key":"B240","first-page":"17","article-title":"Headache: Tension-type Headache","volume":"473","author":"Scripter","year":"2018","journal-title":"FP Essent."},{"key":"B241","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s10194-021-01295-7","article-title":"Role of CGRP Pathway Polymorphisms in Migraine: a Systematic Review and Impact on CGRP mAbs Migraine Therapy","volume":"22","author":"Scuteri","year":"2021","journal-title":"J. Headache Pain"},{"key":"B242","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/pgs-2020-0157","article-title":"Therapy Response Prediction in Major Depressive Disorder: Current and Novel Genomic Markers Influencing Pharmacokinetics and Pharmacodynamics","volume":"22","author":"Shalimova","year":"2021","journal-title":"Pharmacogenomics"},{"key":"B243","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2710.2006.00763.x","article-title":"CYP2D6 Polymorphism and Clinical Effect of the Antidepressant Venlafaxine","volume":"31","author":"Shams","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"key":"B244","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1124\/dmd.30.12.1491","article-title":"Pharmacokinetics of Midazolam and 1'-hydroxymidazolam in Chinese with Different CYP3A5 Genotypes","volume":"30","author":"Shih","year":"2002","journal-title":"Drug Metab. Dispos"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1124\/dmd.30.10.1102","article-title":"Inhibitory Effects of Tricyclic Antidepressants (TCAs) on Human Cytochrome P450 Enzymes In Vitro: Mechanism of Drug Interaction between TCAs and Phenytoin","volume":"30","author":"Shin","year":"2002","journal-title":"Drug Metab. Dispos"},{"key":"B246","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1526-4610.1996.3609547.x","article-title":"Divalproex Sodium in Headache: Literature Review and Clinical Guidelines","volume":"36","author":"Silberstein","year":"1996","journal-title":"Headache"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"key":"B248","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and Safety of Topiramate for the Treatment of Chronic Migraine: a Randomized, Double-Blind, Placebo-Controlled Trial","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"B249","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/wnl.55.6.754","article-title":"Practice Parameter: Evidence-Based Guidelines for Migraine Headache (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"key":"B250","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","article-title":"A Common Novel CYP2C19 Gene Variant Causes Ultrarapid Drug Metabolism Relevant for the Drug Response to Proton Pump Inhibitors and Antidepressants","volume":"79","author":"Sim","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"B252","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/01.fpc.0000239974.69464.f2","article-title":"CYP2D6 Worldwide Genetic Variation Shows High Frequency of Altered Activity Variants and No continental Structure","volume":"17","author":"Sistonen","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"B253","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/0018578720931756","article-title":"Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients with Alcohol Withdrawal Syndrome","volume":"56","author":"Skryabin","year":"2021","journal-title":"Hosp. Pharm."},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2019-0026","article-title":"How Do CYP2C19*2 and CYP2C19*17 Genetic Polymorphisms Affect the Efficacy and Safety of Diazepam in Patients with Alcohol Withdrawal Syndrome","volume":"35","author":"Skryabin","year":"2020","journal-title":"Drug Metab. Pers Ther."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.cellsig.2012.01.009","article-title":"Role of Phospholipase C\u03b5 in Physiological Phosphoinositide Signaling Networks","volume":"24","author":"Smrcka","year":"2012","journal-title":"Cell Signal"},{"key":"B256","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3109\/15563650.2014.933230","article-title":"Ergotism and Factitious Hypotension Associated with Interaction of Ergotamine with CYP3A4 Inhibitors","volume":"52","author":"Srisuma","year":"2014","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B257","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1097\/j.pain.0000000000000662","article-title":"Loss-of-function Polymorphisms in the Organic Cation Transporter OCT1 Are Associated with Reduced Postoperative Tramadol Consumption","volume":"157","author":"Stamer","year":"2016","journal-title":"Pain"},{"key":"B258","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1373\/clinchem.2004.041327","article-title":"Amitriptyline or Not, that Is the Question: Pharmacogenetic Testing of CYP2D6 and CYP2C19 Identifies Patients with Low or High Risk for Side Effects in Amitriptyline Therapy","volume":"51","author":"Steimer","year":"2005","journal-title":"Clin. Chem."},{"key":"B259","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","article-title":"Aids to Management of Headache Disorders in Primary Care (2nd Edition) : on Behalf of the European Headache Federation and Lifting the Burden: the Global Campaign against Headache","volume":"20","author":"Steiner","year":"2019","journal-title":"J. Headache Pain"},{"key":"B260","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase \u03b3 Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology"},{"key":"B261","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10194-010-0217-0","article-title":"Prevalence of Headache in Europe: a Review for the Eurolight Project","volume":"11","author":"Stovner","year":"2010","journal-title":"J. Headache Pain"},{"key":"B262","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0333102413515348","article-title":"A Comparative Study of Candesartan versus Propranolol for Migraine Prophylaxis: A Randomised, Triple-Blind, Placebo-Controlled, Double Cross-Over Study","volume":"34","author":"Stovner","year":"2014","journal-title":"Cephalalgia"},{"key":"B263","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/gim.0b013e3182329870","article-title":"Testing for Variants in CYP2C19: Population Frequencies and Testing Experience in a Clinical Laboratory","volume":"14","author":"Strom","year":"2012","journal-title":"Genet. Med."},{"key":"B264","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/j.pain.0000000000001456","article-title":"Flunarizine as Prophylaxis for Episodic Migraine: a Systematic Review with Meta-Analysis","volume":"160","author":"Stubberud","year":"2019","journal-title":"Pain"},{"key":"B265","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2217\/pgs-2019-0031","article-title":"Venlafaxine Pharmacogenetics: a Comprehensive Review","volume":"20","author":"Suwa\u0142a","year":"2019","journal-title":"Pharmacogenomics"},{"key":"B266","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/pharmaceutics12121180","article-title":"Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of New Anti-migraine Drugs-Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies","volume":"12","author":"Szkutnik-Fiedler","year":"2020","journal-title":"Pharmaceutics"},{"key":"B267","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.3390\/toxins7072659","article-title":"Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety","volume":"7","author":"Szok","year":"2015","journal-title":"Toxins (Basel)"},{"key":"B268","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/2193-1801-3-231","article-title":"Cinnarizine for the Prophylaxis of Migraine Associated Vertigo: a Retrospective Study","volume":"3","author":"Taghdiri","year":"2014","journal-title":"Springerplus"},{"key":"B269","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.clineuro.2010.01.002","article-title":"The Influence of Cytochrome Oxidase CYP2A6, CYP2B6, and CYP2C9 Polymorphisms on the Plasma Concentrations of Valproic Acid in Epileptic Patients","volume":"112","author":"Tan","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B270","doi-asserted-by":"publisher","first-page":"11408","DOI":"10.1038\/s41598-020-67948-w","article-title":"Cortical Spreading Depolarisation-Induced Facial Hyperalgesia, Photophobia and Hypomotility Are Ameliorated by Sumatriptan and Olcegepant","volume":"10","author":"Tang","year":"2020","journal-title":"Sci. Rep."},{"key":"B271","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/ijms20122932","article-title":"Migraine: Experimental Models and Novel Therapeutic Approaches","volume":"20","author":"Tardiolo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B272","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/head.13379","article-title":"History and Review of Anti-calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment","author":"Tepper","year":"2018","journal-title":"Headache"},{"key":"B273","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejphar.2010.04.049","article-title":"The Serotonin Transporter Gene Polymorphism STin2 VNTR Confers an Increased Risk of Inconsistent Response to Triptans in Migraine Patients","volume":"641","author":"Terrazzino","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the Acute Treatment of Migraine: a Review and European Consensus","volume":"123","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain"},{"key":"B275","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1046\/j.1365-2125.1999.00923.x","article-title":"Cytochrome P450 Isoforms Involved in Metabolism of the Enantiomers of Verapamil and Norverapamil","volume":"47","author":"Tracy","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2377-8-4","article-title":"Angiotensin-converting Enzyme Gene Insertion\/deletion Polymorphism in Migraine Patients","volume":"8","author":"Tronvik","year":"2008","journal-title":"BMC Neurol."},{"key":"B277","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1097\/01.hjh.0000220419.86149.11","article-title":"Involvement of the Renin-Angiotensin System in Migraine","volume":"24","author":"Tronvik","year":"2006","journal-title":"J. Hypertens. Suppl."},{"key":"B278","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/brain\/awaa388","article-title":"Machine Phenotyping of Cluster Headache and its Response to Verapamil","volume":"144","author":"Tso","year":"2021","journal-title":"Brain"},{"key":"B279","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/HYP.0b013e31825b30f8","article-title":"Genomic Association Analysis Identifies Multiple Loci Influencing Antihypertensive Response to an Angiotensin II Receptor Blocker","volume":"59","author":"Turner","year":"2012","journal-title":"Hypertension"},{"key":"B280","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2217\/pgs-2017-0095","article-title":"OCT1 Pharmacogenetics in Pain Management: Is a Clinical Application within Reach","volume":"18","author":"Tzvetkov","year":"2017","journal-title":"Pharmacogenomics"},{"key":"B281","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/clpt.2011.56","article-title":"Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol","volume":"90","author":"Tzvetkov","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B282","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2217\/14622416.8.5.435","article-title":"Glutathione S-Transferase M1 Null Genotype as a Risk Factor for Carbamazepine-Induced Mild Hepatotoxicity","volume":"8","author":"Ueda","year":"2007","journal-title":"Pharmacogenomics"},{"key":"B283","unstructured":"Tricyclic and Tetracyclic Drugs: Pharmacology, Administration, and Side Effects2016"},{"key":"B284","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40122-020-00159-3","article-title":"An Evidence-Based Review of Fremanezumab for the Treatment of Migraine","volume":"9","author":"Urits","year":"2020","journal-title":"Pain Ther."},{"volume-title":"Carbamazepine (Marketed as Carbatrol, Equetro, Tegreto and Generics) FDA","year":"2007","key":"B285"},{"key":"B286","unstructured":"Phenytoin Drug Label2020"},{"key":"B287","first-page":"90","article-title":"Side Effects of Treatment with Benzodiazepines","volume":"22","author":"Uzun","year":"2010","journal-title":"Psychiatr. Danub"},{"key":"B288","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cll.2016.05.006","article-title":"Fundamentals of Pharmacogenetics in Personalized, Precision Medicine","volume":"36","author":"Valdes","year":"2016","journal-title":"Clin. Lab. Med."},{"key":"B289","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF00228395","article-title":"Valproate and Sodium Currents in Cultured Hippocampal Neurons","volume":"93","author":"Van den Berg","year":"1993","journal-title":"Exp. Brain Res."},{"key":"B290","doi-asserted-by":"publisher","first-page":"567866","DOI":"10.1177\/00912709922008173","article-title":"Nortriptyline E-10-Hydroxylation In Vitro Is Mediated by Human CYP2D6 (High Affinity) and CYP3A4 (Low Affinity): Implications for Interactions with Enzyme-Inducing drugsErratum in","volume":"3939","author":"Venkatakrishnan","year":"19991999","journal-title":"J. Clin. Pharmacolj Clin. Pharmacol."},{"key":"B291","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s13311-018-0615-6","article-title":"Targeted 5-HT1F Therapies for Migraine","volume":"15","author":"Vila-Pueyo","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B292","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4088\/jcp.v69n0912","article-title":"An 8-week, Open-Label Trial of Duloxetine for Comorbid Major Depressive Disorder and Chronic Headache","volume":"69","author":"Volpe","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"B293","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/01.wnl.0000240128.76399.fa","article-title":"Risk of Ischemic Complications Related to the Intensity of Triptan and Ergotamine Use","volume":"67","author":"Wammes-van der Heijden","year":"2006","journal-title":"Neurology"},{"key":"B294","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2125.1996.42712.x","article-title":"The Elimination of Diazepam in Chinese Subjects Is Dependent on the Mephenytoin Oxidation Phenotype","volume":"42","author":"Wan","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/ene.12039","article-title":"Triggers of Migraine and Tension-type Headache in China: a Clinic-Based Survey","volume":"20","author":"Wang","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1528-1167.2006.00414.x","article-title":"Influence of Lamotrigine and Topiramate on MDR1 Expression in Difficult-To-Treat Temporal Lobe Epilepsy","volume":"47","author":"Wang-Tilz","year":"2006","journal-title":"Epilepsia"},{"key":"B297","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0885-3924(94)90200-3","article-title":"Corticosteroids as Adjuvant Analgesics","volume":"9","author":"Watanabe","year":"1994","journal-title":"J. Pain Symptom Manage."},{"key":"B298","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7861\/clinmedicine.15-3-273","article-title":"Drug Therapy in Headache","volume":"15","author":"Weatherall","year":"2015","journal-title":"Clin. Med. (Lond)"},{"key":"B299","first-page":"122","article-title":"Cluster Headache","volume":"88","author":"Weaver-Agostoni","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"B300","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/practneurol-2018-002124","article-title":"Managing Cluster Headache","volume":"19","author":"Wei","year":"2019","journal-title":"Pract. Neurol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1177\/0333102414566200","article-title":"The Place of Corticosteroids in Migraine Attack Management: a 65-year Systematic Review with Pooled Analysis and Critical Appraisal","volume":"35","author":"Woldeamanuel","year":"2015","journal-title":"Cephalalgia."},{"key":"B302","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40266-014-0220-2","article-title":"Considerations in the Treatment of Tension-type Headache in the Elderly","volume":"31","author":"Wrobel Goldberg","year":"2014","journal-title":"Drugs Aging"},{"key":"B303","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s40265-013-0099-y","article-title":"Sumatriptan\/naproxen Sodium: a Review of its Use in Adult Patients with Migraine","volume":"73","author":"Yang","year":"2013","journal-title":"Drugs"},{"key":"B304","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-012-2102-9","article-title":"Therapeutic Potential for Phenytoin: Targeting Na(v)1.5 Sodium Channels to Reduce Migration and Invasion in Metastatic Breast Cancer","volume":"134","author":"Yang","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/head.12205","article-title":"Duloxetine Prophylaxis for Episodic Migraine in Persons without Depression: a Prospective Study","volume":"53","author":"Young","year":"2013","journal-title":"Headache"},{"key":"B306","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FPC.0000000000000364","article-title":"Individuals with CYP2C8 and CYP2C9 Reduced Metabolism Haplotypes Self-Adjusted Ibuprofen Dose in the Coriell Personalized Medicine Collaborative","volume":"29","author":"Zajic","year":"2019","journal-title":"Pharmacogenet Genomics"},{"key":"B307","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bcpt.12776","article-title":"Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity","volume":"121","author":"Zhao","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1468-2982.2007.01300.x","article-title":"A Randomized, Double-Blind, Placebo-Controlled Study of Venlafaxine XR in Out-Patients with Tension-type Headache","volume":"27","author":"Zissis","year":"2007","journal-title":"Cephalalgia"},{"key":"B309","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1111\/bph.15657","article-title":"Pharmacological Treatment of Migraine: Drug Classes, Mechanisms of Action, Clinical Trials and New Treatments","volume":"178","author":"Zobdeh","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B310","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0304-3940(97)00543-0","article-title":"Topiramate Attenuates Voltage-Gated Sodium Currents in Rat Cerebellar Granule Cells","volume":"231","author":"Zona","year":"1997","journal-title":"Neurosci. Lett."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.820214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T16:28:04Z","timestamp":1681403284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.820214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":310,"alternative-id":["10.3389\/fphar.2021.820214"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.820214","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"article-number":"820214"}}